Cytoplasmic TDP-43 inclusion bodies are pathogenic hallmarks for TDP-43 proteinopathies consisting of several neurodegenerative diseases including frontotemporal lobar dementia with tau- and α-synuclein-negative but ubiquitin-positive inclusions (FTLD-TDP), amyotrophic lateral sclerosis (ALS), and a subtype of Alzheimer's disease. The diseases drastically affect the lives of patients and consume huge societal resources. Here, we generated a specific conformational dependent TDP-43 antibody that is capable of recognizing misfolded TDP oligomers, but not the native, nuclear TDP-43. This antibody has potential to facilitate future clinical diagnosis applications.
